{"cluster": 60, "subcluster": 5, "abstract_summ": "Finally, we map the locations of over 4,400 individual amino acid substitutions in the N protein from (~)17,000 SARS-CoV-2 genome sequences, and find that they are strongly clustered in the protein\u2019s N2a linker domain.This work also constitutes a first step in the possible rational design of efficient therapeutic agents aiming at perturbing the interaction between SARS Unique Domain and guanine quadruplexes, hence enhancing the host defenses against the virus.[Image: see text] Structure-based stabilization of protein\u2013protein interactions (PPIs) is a promising strategy for drug discovery.It is currently no specific viral protein targeted therapeutics yet.Herein, we have determined the 2.7 \u00c5 crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein.Herein, we have determined the 2.7 \u00c5 crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein.", "title_summ": "Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in CoronavirusesA structural model for the Coronavirus NucleocapsidThermal induced unfolding refolding of a nucleocapsid COVN proteinRole of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in CoronavirusesStructure-Based Stabilization of Non-native Protein\u2013Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug DesignArchitecture and self-assembly of the SARS-CoV-2 nucleocapsid proteinCrystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sitesCrystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites", "title_abstract_phrases": "Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sitesThe outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths.Structure-Based Stabilization of Non-native Protein\u2013Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design[Image: see text] Structure-based stabilization of protein\u2013protein interactions (PPIs) is a promising strategy for drug discovery.Finally, we map the locations of over 4,400 individual amino acid substitutions in the N protein from (~)17,000 SARS-CoV-2 genome sequences, and find that they are strongly clustered in the protein\u2019s N2a linker domain.Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sitesThe outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually led to worldwide human infections and deaths.It is currently no specific viral protein targeted therapeutics yet."}